COMPOSITIONS FOR AND METHODS OF EVALUATING TUMORS HAVING A SKELETAL MUSCLE ORIGIN

摘要

Myoblastic differentiation biomarkers are provided for evaluating tumors having a skeletal muscle origin. In addition, kits are provided for evaluating expression levels or presence of the biomarkers associated with such tumors. Furthermore, methods are provided for evaluating such tumors via measuring expression levels or presence of the biomarkers in the cytoplasm of cells.